InMed Pharmaceuticals (INM) Prepaid Assets (2020 - 2026)
InMed Pharmaceuticals' (INM) quarterly Prepaid Assets came in at $617211.0 in Q1 2026, up 21.53% year-on-year from $507872.0 in Q1 2025, and down 6.52% quarter-over-quarter from $660280.0 in Q4 2025.
InMed Pharmaceuticals (INM) Prepaid Assets (2020 - 2026) Analysis & Trends
InMed Pharmaceuticals' Prepaid Assets history runs 7 years deep, the most recent figure standing at $617211.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 21.53% year-over-year to $617211.0 in Q1 2026; TTM through Mar 2026 was $617211.0, a 21.53% increase from a year earlier, with the FY2025 full-year figure at $319547.0, down 33.11% from the prior year.
- Prepaid Assets slipped to $617211.0 in Q1 2026 per INM's latest filing, from $660280.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.3 million in Q1 2022 and bottomed at $148882.0 in Q3 2024.
- The 5-year median for Prepaid Assets is $617211.0 (2026), against an average of $611738.6.
- Across the five-year window, Prepaid Assets jumped 488.51% in 2022 and sank 50.14% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $826931.0 in 2022, then surged by 34.59% to $1.1 million in 2023, then tumbled by 42.14% to $643986.0 in 2024, then gained by 2.53% to $660280.0 in 2025, then dropped by 6.52% to $617211.0 in 2026.
- Per Business Quant, the three latest INM Prepaid Assets figures stand at $617211.0 (Q1 2026), $660280.0 (Q4 2025), and $191755.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | InMed Pharmaceuticals | 307,858.50 | -4.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 617,211.00 |
| Dec 31, 2025 | 660,280.00 |
| Sep 30, 2025 | 191,755.00 |
| Jun 30, 2025 | 319,547.00 |
| Mar 31, 2025 | 507,872.00 |
| Dec 31, 2024 | 643,986.00 |
| Sep 30, 2024 | 148,882.00 |
| Jun 30, 2024 | 477,749.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 215,015.00 |
| Jun 30, 2023 | 498,033.00 |
| Mar 31, 2023 | 695,203.00 |
| Dec 31, 2022 | 826,931.00 |
| Sep 30, 2022 | 356,665.00 |
| Jun 30, 2022 | 797,225.00 |
| Mar 31, 2022 | 1.31 Mn |
| Dec 31, 2021 | 140,512.00 |
| Sep 30, 2021 | 322,352.00 |
| Jun 30, 2021 | 956,762.00 |